High-density lipoprotein apolipoproteins in urine: I. Characterization in normal subjects and in patients with proteinuria
| Autor: | L. O. Henderson, Z. A. R. Gomo, J. E. Myrick |
|---|---|
| Rok vydání: | 1988 |
| Předmět: |
medicine.medical_specialty
Proteinuria Cholesterol Urinary system Biochemistry (medical) Clinical Biochemistry Renal function Urine Excretion chemistry.chemical_compound High-density lipoprotein Endocrinology chemistry Biochemistry Internal medicine medicine lipids (amino acids peptides and proteins) medicine.symptom Lipoprotein |
| Zdroj: | Clinical Chemistry. 34:1775-1780 |
| ISSN: | 1530-8561 0009-9147 |
| DOI: | 10.1093/clinchem/34.9.1772 |
| Popis: | A high-resolution two-dimensional electrophoretic method for protein, with silver staining, has been used to characterize and identify urinary high-density-lipoprotein apolipoproteins (HDL-Apos) and their isoforms in healthy subjects and in patients with kidney disease. Analytical techniques based on both molecular mass and ultracentrifugal flotation properties were used to isolate urinary lipoprotein particles with characteristics identical to those of HDL in plasma. HDL-Apos identified in urine of normal subjects and patients with glomerular proteinuria were Apos A-I, A-II, and C. Five isoforms of Apo A-I were present. Immunostaining of electroblotted proteins further confirmed the presence of HDL-Apos in urine. Creatinine clearance rate was decreased in the patients with proteinuria, and ranged from 32.5 to 40 mL/min. Concentrations of cholesterol and triglycerides in serum were greater in the patients' group, whereas mean HDL-cholesterol (0.68, SD 0.10 mmol/L) and Apo A-I (0.953, SD 0.095 g/L) were significantly (each P less than 0.01) lower. Results of this study suggest that measurement of urinary Apo A-I will reflect excretion of HDL in urine. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|